Skip to content

Provoked Craving Relief Study by NRT

A Pilot Study to Evaluate Relief of Provoked Acute Craving by Nicotine Mouth Strip, Nicorette ® Nicotine Lozenge and Gum

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01476202
Acronym
NRT
Enrollment
120
Registered
2011-11-22
Start date
2011-11-30
Completion date
2012-01-31
Last updated
2013-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

craving, provoked craving, smoking cessation, nicotine replacement therapy, NRT

Brief summary

This study is designed to assess the ability of the mint nicotine mouth strip to relieve provoked cigarette craving in light smokers compared to nicotine lozenge and nicotine gum.

Interventions

DRUGnicotine

nicotine in the form of a mouth strip, lozenge and gum

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Smoking Status: Current cigarette smokers who have smoked regularly for at least a year and smoke their first cigarette more than 30 minutes after waking up.

Exclusion criteria

* Allergy/Intolerance: Known or suspected intolerance or hypersensitivity to nicotine (or closely related compounds) or any of the stated ingredients in formulation. * Prior Concomitant Medication: a. Treatment with known enzyme altering agents (e.g. carbamazepine, phenytoin, cimetidine, sodium valporate) within 30 days of the craving provocation visit. b. Use of any prescription psychoactive medication (such as but not limited to antidepressants, antipsychotics, anxiolytics) within 14 days of the craving provocation visit. c. Use of any over-the-counter (OTC) medication that affects central nervous system such as antihistamines, sedating agents, or any compound that would have a sedating effect within 24 hours of the craving provocation visit. d. Use of any nicotine replacement therapy or any other treatment for smoking cessation (e.g. bupropion or varenicline) within one month of screening visit. e. Use of any nicotine containing products at any time during the Provocation/Treatment visit. f. Use of any medications noted in the

Design outcomes

Primary

MeasureTime frameDescription
Mean Change From Baseline in Nicotine Craving Score on a VASBaseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25 and 30 minutes post treatment administrationParticipants completed a nicotine craving assessment consisting of following five items: I have a desire for a cigarette right now, if it were possible I would smoke right now, All I want right now is a cigarette, I have an urge for a cigarette, I crave a cigarette right now. All participants indicated their craving intensity on a pre-drawn 100 mm scale ranging from 0 (disagree) to 100 (agree). At the end of the craving assessment period, mean VAS score was measured.

Secondary

MeasureTime frameDescription
Log Transformed Area Under the Curve of Nicotine Craving Score (AUC)Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25, and 30 minutes post treatment administrationAUC between the baseline (pre-dose) and the time of measurement of craving on-treatment was determined.

Countries

United States

Participant flow

Recruitment details

Participants were recruited at the clinical site.

Pre-assignment details

Of 140 screened participants, 120 were randomized while 17 participants were screen failures, and 3 participants were not randomized due to other reasons.

Participants by arm

ArmCount
Nicotine Mouth Strip 2.5 mg
Participants self administered a single dose of 2.5 mg nicotine mouth strip.
40
Nicotine Lozenge 2 mg
Participants self administered a single dose of 2 mg nicotine lozenge.
40
Nicotine Gum 2 mg
Participants self administered a single dose of 2 mg nicotine lozenge.
40
Total120

Baseline characteristics

CharacteristicNicotine Mouth Strip 2.5 mgNicotine Lozenge 2 mgNicotine Gum 2 mgTotal
Age Continuous35.5 Years
STANDARD_DEVIATION 11.4
34.8 Years
STANDARD_DEVIATION 10.9
37.4 Years
STANDARD_DEVIATION 11.5
35.0 Years
STANDARD_DEVIATION 11.2
Sex: Female, Male
Female
22 Participants23 Participants27 Participants72 Participants
Sex: Female, Male
Male
18 Participants17 Participants13 Participants48 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
1 / 404 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 400 / 40

Outcome results

Primary

Mean Change From Baseline in Nicotine Craving Score on a VAS

Participants completed a nicotine craving assessment consisting of following five items: I have a desire for a cigarette right now, if it were possible I would smoke right now, All I want right now is a cigarette, I have an urge for a cigarette, I crave a cigarette right now. All participants indicated their craving intensity on a pre-drawn 100 mm scale ranging from 0 (disagree) to 100 (agree). At the end of the craving assessment period, mean VAS score was measured.

Time frame: Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25 and 30 minutes post treatment administration

Population: Intent to Treat (ITT) Population: All randomized participants who had at least one dose of medication and provided at least one craving assessment measurement on treatment. The imputation of missing craving score was based on last observation carried forward (LOCF) technique.

ArmMeasureGroupValue (MEAN)Dispersion
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS7 minutes-39.0 Score on a scaleStandard Deviation 33.2
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS30 minutes-45.2 Score on a scaleStandard Deviation 35.3
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS15 minutes-45.2 Score on a scaleStandard Deviation 33.3
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS10 minutes-43.9 Score on a scaleStandard Deviation 31.8
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS50 seconds-11.3 Score on a scaleStandard Deviation 17.2
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS25 minutes-47.3 Score on a scaleStandard Deviation 33.8
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS5 minutes-35.8 Score on a scaleStandard Deviation 31
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS3 minutes-28.2 Score on a scaleStandard Deviation 28.8
Nicotine Mouth Strip 2.5 mgMean Change From Baseline in Nicotine Craving Score on a VAS20 minutes-47.9 Score on a scaleStandard Deviation 30
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS10 minutes-30.0 Score on a scaleStandard Deviation 26
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS50 seconds-1.7 Score on a scaleStandard Deviation 6
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS3 minutes-12.0 Score on a scaleStandard Deviation 20.7
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS5 minutes-18.3 Score on a scaleStandard Deviation 22.8
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS7 minutes-25.5 Score on a scaleStandard Deviation 27.2
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS15 minutes-34.4 Score on a scaleStandard Deviation 29.1
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS20 minutes-37.4 Score on a scaleStandard Deviation 30.1
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS25 minutes-40.7 Score on a scaleStandard Deviation 30.9
Nicotine Lozenge 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS30 minutes-42.8 Score on a scaleStandard Deviation 32.1
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS5 minutes-27.2 Score on a scaleStandard Deviation 24
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS50 seconds-4.6 Score on a scaleStandard Deviation 9
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS20 minutes-42.7 Score on a scaleStandard Deviation 31.6
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS3 minutes-17.6 Score on a scaleStandard Deviation 18.4
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS30 minutes-42.3 Score on a scaleStandard Deviation 31
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS10 minutes-38.4 Score on a scaleStandard Deviation 29.9
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS7 minutes-33.8 Score on a scaleStandard Deviation 27.5
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS25 minutes-43.5 Score on a scaleStandard Deviation 29.7
Nicotine Gum 2 mgMean Change From Baseline in Nicotine Craving Score on a VAS15 minutes-40.2 Score on a scaleStandard Deviation 30.7
Secondary

Log Transformed Area Under the Curve of Nicotine Craving Score (AUC)

AUC between the baseline (pre-dose) and the time of measurement of craving on-treatment was determined.

Time frame: Baseline, 50 seconds, 3, 5, 7, 10, 15, 20, 25, and 30 minutes post treatment administration

Population: Intent to Treat (ITT) Population: All randomized participants who had at least one dose of medication and provided at least one craving assessment measurement on treatment. The imputation of missing craving score was based on LOCF technique.

ArmMeasureGroupValue (LOG_MEAN)
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-7 minutes)5.8 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-30 minutes)6.8 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-15 minutes)6.3 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-10 minutes)6.0 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-50 seconds)4.0 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-25 minutes)6.7 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-5 minutes)5.5 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-3 minutes)5.1 Score on a scale*minutes
Nicotine Mouth Strip 2.5 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-20 minutes)6.5 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-10 minutes)6.3 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-50 seconds)4.1 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-3 minutes)5.3 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-5 minutes)5.7 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-7 minutes)6.0 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-15 minutes)6.6 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-20 minutes)6.8 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-25 minutes)6.9 Score on a scale*minutes
Nicotine Lozenge 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-30 minutes)7.1 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-5 minutes)5.7 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-50 seconds)4.1 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-20 minutes)6.7 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-3 minutes)5.2 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-30 minutes)7.0 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-10 minutes)6.2 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-7 minutes)5.9 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-25 minutes)6.8 Score on a scale*minutes
Nicotine Gum 2 mgLog Transformed Area Under the Curve of Nicotine Craving Score (AUC)AUC (0-15 minutes)6.5 Score on a scale*minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026